Literature DB >> 16523124

Spinal infections: diagnostic tests and imaging studies.

Howard S An1, J Alex Seldomridge.   

Abstract

UNLABELLED: Clinical signs and symptoms caused by spinal infections often are subtle and insidious; therefore, clinical suspicion in patients with nonmechanical pain is important in making the correct diagnosis in the early stage of disease. Serologic tests such as erythrocyte sedimentation rate and C-reactive protein are quite sensitive, but specificity is relatively low. Imaging tests include plain radiographs, radionuclide studies, computed tomography scan, and magnetic resonance imaging. Changes on plain radiographs appear at least 3 to 4 weeks after the onset of disease. Bone scan is a sensitive but not a specific test. Computed tomography provides structural details in the bone and intervertebral disc but magnetic resonance imaging is a superior imaging test for diagnosing infections earlier and more accurately. In many patients, percutaneous or open biopsy is required to make the definitive diagnosis of discitis or osteomyelitis and the organism responsible for the infection. Early and accurate diagnosis of spinal infections will lead to less invasive treatment for the patient. LEVEL OF EVIDENCE: Level V (Expert Opinion). Please see the Guidelines for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Year:  2006        PMID: 16523124     DOI: 10.1097/01.blo.0000203452.36522.97

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  65 in total

1.  Diagnostic yield of fluoroscopy-guided biopsy for infectious spondylitis.

Authors:  B J Kim; J W Lee; S J Kim; G Y Lee; H S Kang
Journal:  AJNR Am J Neuroradiol       Date:  2012-05-24       Impact factor: 3.825

2.  Spontaneous abscess of the lumbar spine presenting as subacute back pain.

Authors:  Jon M Dickson; Daniel J Warren; Ann L N Chapman; Unni Anoop; Haleema Hayat; Debapriya Bhattacharya
Journal:  BMJ Case Rep       Date:  2010-02-16

3.  Combination of Imaging Features and Clinical Biomarkers Predicts Positive Pathology and Microbiology Findings Suggestive of Spondylodiscitis in Patients Undergoing Image-Guided Percutaneous Biopsy.

Authors:  S Kihira; C Koo; K Mahmoudi; T Leong; X Mei; B Rigney; A Aggarwal; A H Doshi
Journal:  AJNR Am J Neuroradiol       Date:  2020-06-18       Impact factor: 3.825

4.  Recent advances: infections of the spine.

Authors:  Frank L Acosta; Luis F Galvez; Henry E Aryan; Christopher P Ames
Journal:  Curr Infect Dis Rep       Date:  2006-09       Impact factor: 3.725

5.  Delayed diagnosis of odontoid peg osteomyelitis with bilateral X and XII cranial nerve palsies.

Authors:  Faisal Bashir Chaudhry; Samavia Raza; Usman Ahmad
Journal:  BMJ Case Rep       Date:  2019-03-31

6.  [Radiological diagnostics of inflammatory spinal diseases: what is the state of the art?].

Authors:  M Eichler; M-A Weber; S Hähnel; C H Rehnitz
Journal:  Orthopade       Date:  2012-09       Impact factor: 1.087

7.  Infectious spondylodiscitis: diagnosis and treatment.

Authors:  Michael H Amini; Gary A Salzman
Journal:  Mo Med       Date:  2013 Jan-Feb

Review 8.  Expanding role of 18F-fluoro-D-deoxyglucose PET and PET/CT in spinal infections.

Authors:  Filip Gemmel; Paul C Rijk; James M P Collins; Thierry Parlevliet; Katrin D Stumpe; Christopher J Palestro
Journal:  Eur Spine J       Date:  2010-01-06       Impact factor: 3.134

9.  Pyogenic vertebral osteomyelitis: identification of microorganism and laboratory markers used to predict clinical outcome.

Authors:  Sang Hoon Yoon; Sang Ki Chung; Ki-Jeong Kim; Hyun-Jib Kim; Yong Jun Jin; Hong Bin Kim
Journal:  Eur Spine J       Date:  2009-11-24       Impact factor: 3.134

10.  CT-guided fine-needle aspiration in vertebral osteomyelitis: true usefulness of a common practice.

Authors:  Enrique Marco de Lucas; Andrés González Mandly; Agustín Gutiérrez; Raúl Pellón; Laura Martín-Cuesta; Javier Izquierdo; Elena Sánchez; Eva Ruiz; Fernando Quintana
Journal:  Clin Rheumatol       Date:  2008-11-29       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.